Govt sops likely for drug exports avoiding Europe

Image
Press Trust Of India New Delhi
Last Updated : Jan 20 2013 | 12:21 AM IST

The Centre may give sops to drug exporters for shipments to Africa and Latin America through a route that would avoid passing through Europe, while it prepares to drag the European Union (EU) to the World Trade Organization (WTO) over seizure of consignments of Indian pharma companies.

EU has seized Indian generic drugs en route Latin America and Africa on several occasions in the recent times, citing patent violations.

The Department of Pharmaceuticals has submitted a freight subsidy scheme for exporters to the commerce ministry so that they could take alternative routes and avoid transit through Europe, which is a shorter route with better connectivity.

“(The) Ministry of Commerce has agreed with the (subsidy) scheme. I think they will introduce it,” Department of Pharmaceuticals Secretary Ashok Kumar said on the sidelines of a Ficci function today.

Kumar also said the government would take up the issue of Indian generic drug seizure by EU at WTO.

“We are going to WTO,” Kumar said when asked what the government was doing to help exporters against drug seizures.

Commenting on the Centre’s move, Indian Pharmaceutical Alliance Secretary General D G Shah said: “India should assert the right to free trade and right to passage according to the WTO free trade norms.”

The latest incident of seizure was in October at Paris airport when consignment of generic anti-clotting tablets ‘clopidogrel’, made by a Mumbai-based drug company for Venezuela, was confiscated by French authorities.

In February and March, the Netherlands had confiscated blood pressure control and anti-HIV drugs going to Brazil, Columbia and Nigeria on grounds of alleged patent infringement. The consignments were sent by Dr Reddy’s Laboratories and Aurobindo Pharmaceuticals.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 26 2009 | 12:57 AM IST

Next Story